A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide
Titel:
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide
Auteur:
Wang, Eunice S Lyons, Roger M Larson, Richard A Gandhi, Sunil Liu, Delong Matei, Carmen Scott, Bart Hu, Kuolung Yang, Allen S